Latest Fibroblast growth factor Stories
- Company on track to file IND and initiate Phase 1 clinical trial in mid-2015 - CAMBRIDGE, Mass., April 24, 2015 /PRNewswire/ -- Blueprint Medicines today announced new preclinical data demonstrating
MARIETTA, Ga., May 6, 2014 /PRNewswire/ -- MiMedx Group, Inc.
PISCATAWAY, N.J., Feb. 19, 2014 /PRNewswire/ -- PBL Assay Science announces a licensing agreement with HumanZyme, Inc.
Researchers writing in the new open access online journal eLife say that a little stress can actually be good for you.
In "before" and "after" photos from advertisements for wound-healing ointments, bandages and antibiotic creams, we see an injury transformed from an inflamed red gash to smooth and flawless skin.
Once considered merely a passive link between proteins that matter, Grb2 - pronounced "grab2" - actually lives up to its nickname with its controlling grip on an important cell signaling pathway, scientists at The University of Texas MD Anderson Cancer Center report in the June 22 issue of Cell.
Despite the promise associated with the therapeutic use of human stem cells, a complete understanding of the mechanisms that control the fundamental question of whether a stem cell becomes a specific cell type within the body or remains a stem cell has—until now—eluded scientists.
Scientists have confirmed the feasibility of using a new drug delivery system â€” the basis for a battery-powered skin patch â€” to administer medication that shows promise for treating peripheral artery disease (PAD) and healing stubborn skin ulcers and burns.
When the human genome project produced a map of human genes, the number of genes in humans turned out to be relatively small, approximately the same number as in primitive nematode worms.
- Emitting flashes of light; glittering.